Outpatient treatment of COVID-19 and incidence of post-COVID-19 condition over 10 months (COVID-OUT): a multicentre, randomised, quadruple-blind, parallel-group, phase 3 trial.

Bramante CT, Buse JB, Liebovitz DM, Nicklas JM, Puskarich MA, Cohen K, Belani HK, Anderson BJ, Huling JD, Tignanelli CJ, Thompson JL, Pullen M, Wirtz EL, Siegel LK, Proper JL, Odde DJ, Klatt NR, Sherwood NE, Lindberg SM, Karger AB, Beckman KB, Erickson SM, Fenno SL, Hartman KM, Rose MR, Mehta T, Patel B, Griffiths G, Bhat NS, Murray TA, Boulware DR, COVID-OUT Study Team

Open source

DOI
10.1016/s1473-3099(23)00299-2
Published
2023 Oct
Container
The Lancet. Infectious diseases
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/s1473-3099-23-00299-2,
  title = {Outpatient treatment of COVID-19 and incidence of post-COVID-19 condition over 10 months (COVID-OUT): a multicentre, randomised, quadruple-blind, parallel-group, phase 3 trial.},
  author = {Bramante CT and Buse JB and Liebovitz DM and Nicklas JM and Puskarich MA and Cohen K and Belani HK and Anderson BJ and Huling JD and Tignanelli CJ and Thompson JL and Pullen M and Wirtz EL and Siegel LK and Proper JL and Odde DJ and Klatt NR and Sherwood NE and Lindberg SM and Karger AB and Beckman KB and Erickson SM and Fenno SL and Hartman KM and Rose MR and Mehta T and Patel B and Griffiths G and Bhat NS and Murray TA and Boulware DR and COVID-OUT Study Team},
  year = {2023},
  journal = {The Lancet. Infectious diseases},
  doi = {10.1016/s1473-3099(23)00299-2},
  url = {https://doi.org/10.1016/s1473-3099(23)00299-2}
}

RIS

TY  - JOUR
TI  - Outpatient treatment of COVID-19 and incidence of post-COVID-19 condition over 10 months (COVID-OUT): a multicentre, randomised, quadruple-blind, parallel-group, phase 3 trial.
AU  - Bramante CT
AU  - Buse JB
AU  - Liebovitz DM
AU  - Nicklas JM
AU  - Puskarich MA
AU  - Cohen K
AU  - Belani HK
AU  - Anderson BJ
AU  - Huling JD
AU  - Tignanelli CJ
AU  - Thompson JL
AU  - Pullen M
AU  - Wirtz EL
AU  - Siegel LK
AU  - Proper JL
AU  - Odde DJ
AU  - Klatt NR
AU  - Sherwood NE
AU  - Lindberg SM
AU  - Karger AB
AU  - Beckman KB
AU  - Erickson SM
AU  - Fenno SL
AU  - Hartman KM
AU  - Rose MR
AU  - Mehta T
AU  - Patel B
AU  - Griffiths G
AU  - Bhat NS
AU  - Murray TA
AU  - Boulware DR
AU  - COVID-OUT Study Team
PY  - 2023
JO  - The Lancet. Infectious diseases
DO  - 10.1016/s1473-3099(23)00299-2
UR  - https://doi.org/10.1016/s1473-3099(23)00299-2
ER  - 

APA

CT, B., JB, B., DM, L., JM, N., MA, P., K, C., HK, B., BJ, A., JD, H., CJ, T., JL, T., M, P., EL, W., LK, S., JL, P., DJ, O., NR, K., NE, S., SM, L., AB, K., KB, B., SM, E., SL, F., KM, H., MR, R., T, M., B, P., G, G., NS, B., TA, M., DR, B., & Team, C. S. (2023). Outpatient treatment of COVID-19 and incidence of post-COVID-19 condition over 10 months (COVID-OUT): a multicentre, randomised, quadruple-blind, parallel-group, phase 3 trial.. The Lancet. Infectious diseases. https://doi.org/10.1016/s1473-3099(23)00299-2

Source records